230 related articles for article (PubMed ID: 10361113)
1. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation.
Ilaria RL; Hawley RG; Van Etten RA
Blood; 1999 Jun; 93(12):4154-66. PubMed ID: 10361113
[TBL] [Abstract][Full Text] [Related]
2. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
4. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
[TBL] [Abstract][Full Text] [Related]
5. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
[TBL] [Abstract][Full Text] [Related]
7. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
Chakraborty A; Dyer KF; Tweardy DJ
Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of STAT5 by a point mutation in the SH2 domain.
Ariyoshi K; Nosaka T; Yamada K; Onishi M; Oka Y; Miyajima A; Kitamura T
J Biol Chem; 2000 Aug; 275(32):24407-13. PubMed ID: 10823841
[TBL] [Abstract][Full Text] [Related]
9. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
Friedrich K; Kammer W; Erhardt I; Brändlein S; Sebald W; Moriggl R
Int Immunol; 1999 Aug; 11(8):1283-94. PubMed ID: 10421786
[TBL] [Abstract][Full Text] [Related]
10. Naturally occurring dominant negative variants of Stat5.
Wang D; Stravopodis D; Teglund S; Kitazawa J; Ihle JN
Mol Cell Biol; 1996 Nov; 16(11):6141-8. PubMed ID: 8887644
[TBL] [Abstract][Full Text] [Related]
11. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor.
Shimoda K; Feng J; Murakami H; Nagata S; Watling D; Rogers NC; Stark GR; Kerr IM; Ihle JN
Blood; 1997 Jul; 90(2):597-604. PubMed ID: 9226159
[TBL] [Abstract][Full Text] [Related]
12. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation.
Mui AL; Wakao H; Kinoshita T; Kitamura T; Miyajima A
EMBO J; 1996 May; 15(10):2425-33. PubMed ID: 8665850
[TBL] [Abstract][Full Text] [Related]
13. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.
Gouilleux F; Pallard C; Dusanter-Fourt I; Wakao H; Haldosen LA; Norstedt G; Levy D; Groner B
EMBO J; 1995 May; 14(9):2005-13. PubMed ID: 7744007
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
[TBL] [Abstract][Full Text] [Related]
15. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
Okajima Y; Matsumura I; Nishiura T; Hashimoto K; Yoshida H; Ishikawa J; Wakao H; Yoshimura A; Kanakura Y; Tomiyama Y; Matsuzawa Y
J Biol Chem; 1998 Sep; 273(36):22877-83. PubMed ID: 9722506
[TBL] [Abstract][Full Text] [Related]
19. IL-3-induced enhancement of retinoic acid receptor activity is mediated through Stat5, which physically associates with retinoic acid receptors in an IL-3-dependent manner.
Si J; Collins SJ
Blood; 2002 Dec; 100(13):4401-9. PubMed ID: 12393611
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Selective activation of Jak2, Stat3, and Stat5b.
Al-Shami A; Mahanna W; Naccache PH
J Biol Chem; 1998 Jan; 273(2):1058-63. PubMed ID: 9422769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
